HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen S Hecht Selected Research

O-(6)-methylguanine

4/2022Metabolic Activation and DNA Interactions of Carcinogenic N-Nitrosamines to Which Humans Are Commonly Exposed.
1/2020Oral Dosing of Dihydromethysticin Ahead of Tobacco Carcinogen NNK Effectively Prevents Lung Tumorigenesis in A/J Mice.
1/2017Pilot in Vivo Structure-Activity Relationship of Dihydromethysticin in Blocking 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-Induced O6-Methylguanine and Lung Tumor in A/J Mice.
1/2014Kava blocks 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in association with reducing O6-methylguanine DNA adduct in A/J mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephen S Hecht Research Topics

Disease

100Neoplasms (Cancer)
07/2022 - 01/2002
66Lung Neoplasms (Lung Cancer)
01/2020 - 04/2002
65Carcinogenesis
04/2022 - 09/2002
9Inflammation (Inflammations)
12/2021 - 01/2014
7Adenoma (Adenomas)
01/2021 - 09/2005
7Esophageal Neoplasms (Esophageal Cancer)
12/2016 - 02/2003
5Tobacco Use Disorder (Nicotine Dependence)
01/2022 - 09/2007
5Head and Neck Neoplasms (Head and Neck Cancer)
09/2017 - 03/2012
3Hepatocellular Carcinoma (Hepatoma)
01/2019 - 11/2005
3Squamous Cell Carcinoma of Head and Neck
09/2017 - 08/2013
3Leukemia
12/2015 - 04/2010
3Adenocarcinoma of Lung
02/2010 - 09/2005
3Adenocarcinoma
02/2010 - 09/2005
2Substance Withdrawal Syndrome (Withdrawal Symptoms)
12/2019 - 01/2011
2Carcinoma (Carcinomatosis)
01/2018 - 03/2012
2Liver Neoplasms (Liver Cancer)
07/2014 - 12/2004
1Marijuana Use
01/2020
1Schizophrenia (Dementia Praecox)
12/2019
1Psychotic Disorders (Schizoaffective Disorder)
12/2019
1Bipolar Disorder (Manic Depressive Psychosis)
12/2019

Drug/Important Bio-Agent (IBA)

89CarcinogensIBA
07/2022 - 01/2002
63Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2002
47SmokeIBA
07/2022 - 01/2002
43DNA AdductsIBA
04/2022 - 08/2002
294- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA
01/2022 - 04/2002
25Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
03/2020 - 12/2002
23NitrosaminesIBA
04/2022 - 02/2003
22DNA (Deoxyribonucleic Acid)IBA
04/2022 - 08/2002
18NicotineFDA Link
01/2022 - 10/2003
17CotinineIBA
11/2019 - 09/2007
15N'-nitrosonornicotine (nitrosonornicotine)IBA
01/2022 - 05/2002
144- (methylnitrosamino)- 1- (3- pyridyl)- 1- butan- 1- olIBA
12/2019 - 03/2008
14Benzo(a)pyreneIBA
01/2014 - 01/2002
9phenanthreneIBA
01/2016 - 12/2004
8Acrolein (Aqualin)IBA
01/2020 - 04/2007
8GlucuronidesIBA
08/2015 - 04/2005
7phenethyl isothiocyanate (PEITC)IBA
01/2022 - 09/2002
7Benzene (Benzole)IBA
01/2022 - 01/2002
7nitrosamine 4- (methylnitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA
01/2018 - 07/2008
7indole-3-carbinolIBA
01/2016 - 06/2004
6AcetaldehydeIBA
01/2021 - 02/2006
5Tobacco Smoke Pollution (Passive Smoking)IBA
01/2020 - 10/2006
5AcidsIBA
01/2019 - 07/2008
5EnzymesIBA
01/2017 - 04/2005
5IsothiocyanatesIBA
07/2016 - 09/2002
5Epoxy Compounds (Epoxides)IBA
09/2014 - 03/2009
5Inositol (Myoinositol)IBA
09/2010 - 09/2002
4O-(6)-methylguanineIBA
04/2022 - 01/2014
4Formaldehyde (Formol)FDA Link
01/2021 - 08/2007
47,8-dihydromethysticinIBA
01/2020 - 10/2014
4Phosphates (Orthophosphate)IBA
11/2019 - 11/2015
4Dinoprostone (PGE2)FDA Link
01/2019 - 07/2016
4nitrosobenzylmethylamineIBA
01/2016 - 08/2006
43,3'-diindolylmethane (diindolylmethane)IBA
01/2016 - 07/2007
4AflatoxinsIBA
01/2012 - 12/2004
4N- acetyl- S- (N- 2- phenethylthiocarbamoyl)- L- cysteineIBA
09/2010 - 09/2002
4Proteins (Proteins, Gene)FDA Link
11/2009 - 09/2005
3CytochromesIBA
04/2022 - 06/2009
3Environmental CarcinogensIBA
01/2022 - 08/2017
3AldehydesIBA
01/2021 - 06/2011
3CreatinineIBA
01/2020 - 12/2003
37- hydroxy- 5,11- dioxotetranorprostane- 1,16- dioic acidIBA
01/2019 - 01/2019
3CytokinesIBA
01/2016 - 06/2014
3Anthocyanins (Anthocyanin)IBA
01/2016 - 01/2009
31-hydroxypyreneIBA
08/2015 - 03/2008
32-butenal (crotonaldehyde)IBA
01/2015 - 05/2010
3Acetylcysteine (Siran)FDA LinkGeneric
04/2012 - 09/2002
3Glutathione Transferase (Glutathione S-Transferase)IBA
09/2010 - 05/2008
3Glutathione (Reduced Glutathione)IBA
09/2010 - 03/2008
3TransferasesIBA
03/2009 - 09/2005
3Proliferating Cell Nuclear Antigen (PCNA)IBA
12/2008 - 09/2005
3benzyl isothiocyanateIBA
03/2003 - 09/2002
2Environmental Pollutants (Pollutants, Environmental)IBA
01/2020 - 01/2012
2F2-Isoprostanes (F2 Isoprostanes)IBA
01/2019 - 03/2008
2EicosanoidsIBA
01/2019 - 01/2019
2N 30IBA
09/2017 - 12/2003
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
05/2016 - 03/2008
2phenanthrene tetraolIBA
01/2016 - 05/2014
2protocatechuic acidIBA
01/2016 - 06/2014
2Indicators and Reagents (Reagents)IBA
09/2012 - 07/2008
2Ethanol (Ethyl Alcohol)IBA
07/2012 - 11/2008
21,3-butadiene (divinyl)IBA
04/2012 - 01/2002
2Ethylene Oxide (Oxirane)IBA
04/2012 - 01/2002
2r- 1,t- 2,3,c- 4- tetrahydroxy- 1,2,3,4- tetrahydrophenanthreneIBA
11/2011 - 01/2009
2MutagensIBA
04/2010 - 02/2006
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2008 - 11/2008
2Caspase 3 (Caspase-3)IBA
11/2008 - 09/2005
2pyridineIBA
07/2008 - 04/2005
2sulforaphaneIBA
09/2005 - 12/2002
2isothiocyanic acidIBA
09/2005 - 03/2003
2N-NitrosopyrrolidineIBA
01/2005 - 02/2003
24-nitrophenyl myo-inositol-1-phosphateIBA
10/2003 - 02/2003
2Hemoglobins (Hemoglobin)IBA
11/2002 - 04/2002
1Propylene Glycol (1,2 Propanediol)FDA LinkGeneric
12/2021
1Carbon DioxideIBA
01/2021
1quinone (benzoquinone)IBA
11/2020
1trans-1,2-dihydro-1,2-naphthalenediolIBA
03/2020
1Biological ProductsIBA
01/2020

Therapy/Procedure

11Chemoprevention
10/2020 - 08/2002
2Intraperitoneal Injections
01/2021 - 01/2020